AHPX+ Modified-Chitosan Carrier (CN120248173A) vs. Neat Acetyl Hexapeptide-8: Solving the 500 Da Permeation Barrier & High-Acid Serum Formulation

Direct Answer for Cosmetic Formulators & Brand Founders: Native Acetyl Hexapeptide-8 (CAS 616204-22-9, average molecular weight 889.01 g/mol, monoisotopic mass 888.42 Da) is highly water-soluble and polar, which restricts passive diffusion across the lipid-rich stratum corneum (“500 Dalton Rule”). Developed at Suzhou Xilin Technology Co., Ltd. (苏州汐霖生物科技有限公司) by founder Dr. Yiqiong Ji and scientific advisor Dr. Libo Du, AHPX+ (Acetyl Hexapeptide-8 Pro) pairs 1,000 ppm Acetyl Hexapeptide-8 with a patent-pending amphiphilic modified-chitosan carrier (CN120248173A, INCI: Hydrolyzed Chitosan)—retaining 100% standard cosmetic INCI compliance while lifting 8-hour ex-vivo skin permeation to 3.19× (+219.00%) and reducing crow’s-feet wrinkle volume by -38.49% in a 28-day, 33-subject split-face human trial at Guangzhou Quality Supervision & Testing Institute (GQI).

1. Neat Solid Powder (YY/T 10004—2026) vs. AHPX+ 1,000 ppm Delivery Complex

Global R&D and procurement teams frequently receive conflicting supplier quotes because trading brokers blur solid lyophilized peptide powder with diluted liquid compounds. On April 3, 2026, China’s NMPA published voluntary cosmetic/pharmaceutical raw-material industry standard YY/T 10004—2026 (Acetyl Hexapeptide-8) (effective May 1, 2027; read full standard analysis), which draws a strict technical boundary:

  • Neat Solid Powder Scope (Acetyl Hexapeptide-8 Raw Powder): YY/T 10004—2026 applies exclusively to lyophilized solid powder or cake (≥98.0% HPLC purity), explicitly excluding aqueous peptide solutions and sequence analogs, and mandates 2–8 °C refrigerated transport and storage (§7.3–7.4).
  • Carrier-Enhanced Liquid Complex Scope (AHPX+): Supplied as a ready-to-compound 1,000 ppm (0.1%) aqueous delivery system (full INCI: Water, Acetyl Hexapeptide-8, Hydrolyzed Chitosan, Hydroxyacetophenone, Pentylene Glycol), quoted transparently per kilogram of liquid complex for cold-process or emulsion cool-down addition (≤45 °C).
Benchmark Metric Unmodified Acetyl Hexapeptide-8 AHPX+ (Modified Chitosan Complex, CN120248173A)
Ex-Vivo Mouse Skin Permeation (Fluorescence) 1.00× baseline hydrophilic diffusion +82.00% at 2 h (1.82×) and +219.00% at 8 h (3.19×)
In-Vitro Acetylcholine Release Inhibition -18.3% inhibition at 0.05 mg/mL -32.0% inhibition at 0.005 mg/mL (1/10th concentration)
In-Vitro Dermal Matrix Markers (0.01 mg/mL) Single-pathway expression-line focus Type III Collagen +794.1%, Type I Collagen +193.3%, Elastin +73.1% vs. blank
28-Day Split-Face Human Trial (GQI, n = 33, 1% Cream) Separate 56-day 0.05% solution ref (n = 17): -21.92% line volume -25.32% (7d) / -38.49% (28d) crow’s-feet volume, -30.40% length, +17.46% R2 elasticity, -22.58% TEWL

2. Polymer & Oxidation Chemistry Behind CN120248173A

The carrier design inside AHPX+ builds on peer-reviewed polymer and free-radical research published by Dr. Libo Du (ICCAS, Google Scholar 2,800+ citations; see full DOI bibliography), including multi-functionalized chitosan nanoparticle engineering (Carbohydrate Polymers 2018, 10.1016/j.carbpol.2018.04.087), hydroxyethyl-chitosan oxidative protection (Nanomedicine 2014, 10.1016/j.nano.2014.04.001), and early sulfur-oxidation probe studies (Spectrochimica Acta A 2026, 10.1016/j.saa.2026.127460):

  • Reversible Electrostatic & Amphiphilic Self-Assembly: Modified hydrolyzed chitosan forms biocompatible nano-domains that transiently interact with negatively charged corneocyte lipid headgroups, ferrying hydrophilic hexapeptide cargo into deeper epidermal layers without harsh chemical penetration enhancers.
  • Protecting Methionine-3 Against Sulfoxide Degradation: Acetyl Hexapeptide-8 contains a sulfur-bearing methionine residue (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) vulnerable to dissolved-oxygen and trace-metal oxidation. Pairing hydroxyacetophenone + pentylene glycol inside the chitosan microenvironment protects peptide integrity across shelf life.

3. Co-Formulating Hexapeptide With Polyhydroxy Acids (PHA) & Niacinamide

Prestige Western dermocosmetic brands increasingly request multi-tasking “glass-skin” resurfacing + firming serums that combine exfoliating acids, 3%–5% niacinamide, and expression-line peptides in one bottle. Dropping neat peptides into an unbuffered pH 3.0 glycolic acid base causes two immediate failures: acid-catalyzed amide cleavage and niacinamide hydrolysis into flushing nicotinic acid.

At Suzhou Xilin’s Formulation Engineering Lab, we solve this by:

  1. Replacing harsh low-pKa AHA spikes with buffered Polyhydroxy Acids (PHA): Using gluconolactone or lactobionic acid buffered cleanly to pH 4.8–5.4, preserving gentle corneocyte renewal while keeping both niacinamide and Acetyl Hexapeptide-8 inside their non-hydrolytic stability window.
  2. Avoiding Copper Cross-Chelation in Acid Systems: Never put Copper Tripeptide-1 (GHK-Cu) into PHA/AHA formulas; use AHPX+ + Palmitoyl Tripeptide-5 for acidic/niacinamide resurfacing serums, and reserve GHK-Cu for dedicated neutral-pH (5.5–6.8) repair serums or soothing barrier mists.

Ready to evaluate AHPX+ (1,000 ppm complex) alongside neat Acetyl Hexapeptide-8 or custom ODM bases? Visit our Pro-Peptide Science & Flexible ODM Hub to request samples and GQI study summaries.

Related sourcing paths